The <i>APC</i> I1307K variant and male breast cancer risk: a multicenter case-control study in Italy

Abstract Objectives The APC I1307K variant is a known moderate-risk allele for colorectal cancer (CRC), especially among Ashkenazi Jewish (AJ) individuals. However, its role in other cancers, particularly in male breast cancer (MBC), remains unclear. This study aimed to evaluate whether APC I1307K contributes to MBC risk in the Italian (non-AJ) population. Methods A multicenter case-control study was conducted involving 1028 MBC cases and 2,126 geographically matched healthy male controls. Genotyping was performed via Next Generation Sequencing or TaqMan assays. Associations between APC I1307K and MBC risk were analyzed using logistic regression models, including multivariate adjustments for age, enrollment center, and BRCA1/2 status. Results The APC I1307K variant was detected in 4 MBC cases (0.4 %) and 5 controls (0.2 %). No statistically significant association with MBC risk was observed (multivariate odds ratio [OR]=3.7, 95 % CI: 0.8–17.0, p=0.09). Clinical-pathologic comparisons revealed no distinguishing features among variant carriers. None of the carriers harbored BRCA1/2 pathogenic variants (PVs) or had personal histories of CRC or familial adenomatous polyposis. Conclusions These findings suggest that APC I1307K does not confer a significant risk for MBC in the Italian population.

Authors

Institutions

Publication Details

Journal
ONCOLOGIE
Published
2025-12-20
DOI
https://doi.org/10.1515/oncologie-2025-0374
Primary Topic
Male Breast Health Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The APC I1307K variant and male breast cancer risk: a multicenter case-control study in Italy

Livia Manzella, Valentina Zampiga, Daniela Turchetti, Giuseppe Giannini et al.
ONCOLOGIE
Male Breast Health Studies
article

The APC I1307K variant and male breast cancer risk: a multicenter case-control study in Italy

Livia Manzella, Valentina Zampiga, Daniela Turchetti, Giuseppe Giannini, Valentina Arcangeli, Bernardo Bonanni, Ines Zanna, Siranoush Manoukian, Viviana Gismondi, Marco Montagna, Agostino Bucalo, Virginia Porzio, Giovanna Masala, Laura Cortesi, Valentina Silvestri, Daniele Calistri, Virginia Valentini, Laura Ottini, Maria Grazia Tibiletti, Paolo Peterlongo, Alessandra Viel, Paolo Radice, Ileana Carnevali, Antonio Russo
article en

Abstract

Abstract Objectives The APC I1307K variant is a known moderate-risk allele for colorectal cancer (CRC), especially among Ashkenazi Jewish (AJ) individuals. However, its role in other cancers, particularly in male breast cancer (MBC), remains unclear. This study aimed to evaluate whether APC I1307K contributes to MBC risk in the Italian (non-AJ) population. Methods A multicenter case-control study was conducted involving 1028 MBC cases and 2,126 geographically matched healthy male controls. Genotyping was performed via Next Generation Sequencing or TaqMan assays. Associations between APC I1307K and MBC risk were analyzed using logistic regression models, including multivariate adjustments for age, enrollment center, and BRCA1/2 status. Results The APC I1307K variant was detected in 4 MBC cases (0.4 %) and 5 controls (0.2 %). No statistically significant association with MBC risk was observed (multivariate odds ratio [OR]=3.7, 95 % CI: 0.8–17.0, p=0.09). Clinical-pathologic comparisons revealed no distinguishing features among variant carriers. None of the carriers harbored BRCA1/2 pathogenic variants (PVs) or had personal histories of CRC or familial adenomatous polyposis. Conclusions These findings suggest that APC I1307K does not confer a significant risk for MBC in the Italian population.

ONCOLOGIEVol. 28(1)
University of Insubria (IT), University of Modena and Reggio Emilia (IT), Ospedale di Circolo e Fondazione Macchi (IT), Prevention Institute (US), University of Catania (IT), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT), Istituto Oncologico Veneto (IT), Centro di Riferimento Oncologico (IT), Ospedale Policlinico San Martino (IT), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), European Institute of Oncology (IT), Sapienza University of Rome (IT), University of Palermo (IT), University of Bologna (IT)
Dipartimenti di Eccellenza, European Commission, Ministero dell’Istruzione, dell’Università e della Ricerca, Sapienza Università di Roma, Associazione Italiana per la Ricerca sul Cancro
Openalex Percentile: Top 48%
Male Breast Health Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.